Conclusions of the study
The team arrived to a conclusion that revealed a significant amount of curcumin fluorescence in patients with AD as opposed to the patients in the controlled group. “As a developmental outgrowth of the central nervous system that shares many of the brain’s characteristics, the retina may offer a unique opportunity for us to easily and conveniently detect and monitor Alzheimer’s disease. We know that Alzheimer’s begins as many as 10 or 20 years before cognitive decline becomes evident, and we believe that potential treatments may be more effective if they can be started early in the process. Therefore, screening and early detection may be crucial to our efforts to turn the tide against the growing threat of this devastating disease” said Keith L. Black, chairman of the Department of Neurology and director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center.